Skip to search formSkip to main contentSkip to account menu

stage d2

Prostate cancer that has spread to distant lymph nodes or other organs.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
16093 Background: The expression of 9 signaling transduction pathways, important for angiogenesis and apoptosis was identified by… 
2004
2004
4745 Purpose To evaluate whether patients (pts) with advanced prostate cancer (APC), programmed for continuous androgen… 
1996
1996
Based upon prior data suggesting that alpha-interferon possesses chemomodulatory activity, the Southwest Oncology Group conducted… 
1996
1996
To determine whether long-term oral administration of UFT, a combination of 5-fluorouracil and uracil, in addition to… 
1994
1994
A 58-year-old male complaining of pollakisuria, miction pain and back pain visited us Dec. 26, 1979. Rectal examination revealed… 
1993
1993
There is no effective therapy available for stage D2 prostate cancer once patients become refractory to hormonal therapy. In a… 
1992
1992
Background. A characteristic feature of prostatic adenocarcinoma is its great variation in biologic behavior. This variation and… 
1991
1991
Flow cytometric DNA analysis was performed on 34 samples of prostatic carcinoma patients with stage D2 disease to study the…